Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
A versatile spicy peanut chutney that can be used as a spread, marinade, dip or condiment. Kit's Peanut Chutney is homemade using natural ingredients, as well as being vegan nad gluten-free. The company is seeking investment mass produce their products and increase the number of stockists that list their range.
Currently, the products are stocked by nine independent retailers and new outlets are being added every day. To date, more than 600 jars have been sold. By increasing their production, they aim to lower the cost of their products whilst yielding a 73% gross profit margin per jar sold. Wholesaling will yield a gross profit margin of 44% per jar.
days to go:
Expired
investment:
£102,510
Environmentally friendly and nutritiously rich plant-based meals enjoyed by everyone, at any place, any time. The Brook have been serving thousands of customers over the past 5 years at their restaurants and are now launching their ready-to-cook and ready-to-eat vegan foods. The company already has hundreds of customers signed up to try their new ranges and have received press coverage from the BBC.
The new products will be distributed via e-commerce and will be shipped directly to customers. Furthermore, The Brook is currently in discussions with independent and major retailers to sell their products, as well wholesalers including pubs and other restaurants. Funds raised will be used to purchase kitchen equipment, hire staff and carry out marketing campaigns.
days to go:
Expired
investment:
£170,481
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
The Cotswold Distilling Company Limited (trading as The Cotswolds Distillery) was founded in 2013 and is, in its director’s opinion, well on the way to becoming a leading producer of world class ultra-premium whisky, gin and other branded spirits, as well as a premier tourist/visitor experience in the Cotswolds. www.cotswoldsdistillery.com
days to go:
Expired
investment:
£1,001,000
To help reduce wasted food, Daily Dose source 'wonky' fruit and veg for their organic cold-pressed juices. They sell over 40,000 drinks on average every month and supply their products to more than 150 stockists, as well as launching a café in 2017. They are currently researching methods to extend the shelf life of their juices. Daily Dose moved from a 500sq ft. to a 2500sq ft. facility in 2016, now they are raising funds to triple the size of their site.
days to go:
Expired
investment:
£305,740
BeerBods aim is to get more people drinking better beer. Since their first raise in 2014 subscriber numbers are up four-fold, with revenue up five-fold and the team six-fold. They are now seeking further investment with the aim to become the leading independent online beer retailer in the UK.
days to go:
Expired
investment:
£264,550
